Aspirin in the prevention of cancer – Author's reply

Slides:



Advertisements
Similar presentations
The Microbiome and Cancer: Is the ‘Oncobiome’ Mirage Real? Ryan M. Thomas, Christian Jobin Trends in Cancer Volume 1, Issue 1, Pages (September 2015)
Advertisements

Adjuvant bisphosphonate treatment in early breast cancer: meta-analyses of individual patient data from randomised trials The Lancet Volume 386, Issue.
Crohn's disease Prof Daniel C Baumgart, MD, Prof William J Sandborn, MD The Lancet Volume 380, Issue 9853, Pages (November 2012) DOI: /S (12)
Volume 376, Issue 9753, Pages (November 2010)
Volume 370, Issue 9586, Pages (August 2007)
Volume 357, Issue 9273, Pages (June 2001)
Volume 357, Issue 9257, Pages (March 2001)
Pharmacogenetics and future drug development and delivery
The effects of lowering LDL cholesterol with statin therapy in people at low risk of vascular disease: meta-analysis of individual data from 27 randomised.
Volume 376, Issue 9734, Pages (July 2010)
Thank God for Richard Dawkins?
Long-term effects of hormone replacement therapy
Meta-analysis of randomised controlled trials
Volume 376, Issue 9734, Pages (July 2010)
Volume 392, Issue 10145, Pages (August 2018)
Long-term effects of hormone replacement therapy
Gareth L Ackland, Maurizio Cecconi, Rupert M Pearse 
Underestimate of annual malaria imports to Canada – Author reply
Volume 379, Issue 9811, Pages (January 2012)
Volume 390, Issue 10093, Pages (July 2017)
Trends in virological and clinical outcomes in individuals with HIV-1 infection and virological failure of drugs from three antiretroviral drug classes:
The effects of lowering LDL cholesterol with statin therapy in people at low risk of vascular disease: meta-analysis of individual data from 27 randomised.
Volume 365, Issue 9466, Pages (April 2005)
Adjuvant chemotherapy for rectal cancer – Authors' reply
Incident diabetes in clinical trials of antihypertensive drugs
Ovarian cancer screening: UKCTOCS trial – Authors' reply
Mortality risk with dual antiplatelet therapy?
Volume 9, Issue 9, Pages (September 2010)
Arnaud Chiolero  The Lancet Public Health 
HIV myths should not be resuscitated
General Practice Research Database for prescribing analysis
Effect of development assistance on domestic health expenditures
Adrian Martineau  The Lancet Respiratory Medicine 
Glucose-lowering drugs or strategies and cardiovascular outcomes in patients with or at risk for type 2 diabetes: a meta-analysis of randomised controlled.
MRC/BHF Heart Protection Study
Volume 390, Issue 10093, Pages (July 2017)
Confessions of a journal junkie
Infant-feeding patterns and HIV-1 transmission
Volume 376, Issue 9753, Pages (November 2010)
Volume 371, Issue 9627, Pages (May 2008)
Telling it like it isn't: truth and lies in a post-9/11 world
C-reactive protein concentration and the vascular benefits of statin therapy: an analysis of 20 536 patients in the Heart Protection Study  Heart Protection.
Volume 377, Issue 9771, Pages (March 2011)
Anna J Dare, Calvin Ke, Wilson Suraweera, Peter Rodriguez, Prabhat Jha 
Thank God for Richard Dawkins?
Volume 373, Issue 9658, Pages (January 2009)
Department of Error The Lancet Volume 369, Issue 9564, (March 2007)
Low-technology approaches
Volume 375, Issue 9714, Pages (February 2010)
Muh Geot Wong, Vlado Perkovic  The Lancet Diabetes & Endocrinology 
Thank you to our diverse (but not diverse enough) reviewers
Vitamin D status and ill health – Author's reply
Incidence and prevalence of dementia associated with transient ischaemic attack and stroke: analysis of the population-based Oxford Vascular Study  Sarah.
Matthieu J Guitton  The Lancet Planetary Health 
Arlene Chan, Marc Buyse, Bin Yao  The Lancet Oncology 
Steven A Narod  The Lancet  Volume 349, Issue 9068, (June 1997)
Impact of renal function on the effects of LDL cholesterol lowering with statin-based regimens: a meta-analysis of individual participant data from 28.
Effectiveness of strategies to improve health-care provider practices in low-income and middle-income countries: a systematic review  Alexander K Rowe,
Genetic enhancement of radionuclide cancer therapy
Effects on 11-year mortality and morbidity of lowering LDL cholesterol with simvastatin for about 5 years in 20 536 high-risk individuals: a randomised.
ECASS-II: intravenous alteplase in acute ischaemic stroke
Volume 388, Issue 10042, Pages (July 2016)
Jeffrey T Howard, Alexis R Santos-Lozada  The Lancet Planetary Health 
Are new drugs for schizophrenia better than old ones? – Authors' reply
Clinic attendance and disengagement of young adults with type 1 diabetes after transition of care from paediatric to adult services (TrACeD): a randomised,
Effect of consent rituals on mortality in emergency care research
Pleurodesis for primary spontaneous pneumothorax – Authors' reply
Volume 349, Issue 9062, Pages (May 1997)
Autism, maths, and sex: the special triangle
Volume 374, Issue 9694, Pages (September 2009)
Presentation transcript:

Aspirin in the prevention of cancer – Author's reply Peter M Rothwell  The Lancet  Volume 377, Issue 9778, Pages 1651-1652 (May 2011) DOI: 10.1016/S0140-6736(11)60670-3 Copyright © 2011 Elsevier Ltd Terms and Conditions

Figure Pooled analysis of the effect of randomised allocation to aspirin versus control for a duration of about 5–8 years on the 20-year risk of death due to adenocarcinoma of the oesophagus, during, and after two trials in patients without previous vascular events1,2 The Lancet 2011 377, 1651-1652DOI: (10.1016/S0140-6736(11)60670-3) Copyright © 2011 Elsevier Ltd Terms and Conditions

Feedback: Privacy Policy Feedback
Do Not Sell My Personal Information
About project: SlidePlayer Terms of Service

© 2024 SlidePlayer.com. Inc. All rights reserved.